Skip to Content
Authors Wilson GC, Maithel SK, Bentrem D, Abbott DE, Weber S, Cho C, Martin RC, Scoggins CR, Kim HJ, Merchant NB, Kooby DA, Edwards MJ, Ahmad SA
Author Profile(s)
Journal J. Am. Coll. Surg. Volume: 224 Issue: 4 Pages: 461-469
Publish Date 2017 Apr
PubMed ID 28088598
Abstract

Controversy persists regarding the management of patients with intraductal papillary mucinous neoplasms (IPMN). International consensus guidelines stratify patients into high-risk, worrisome, and low risk categories.The medical records of 7 institutions were reviewed for patients who underwent surgical management of IPMN between 2000 and 2015.There were 324 patients included in the analysis; 60.4% of patients had main-duct/mixed type, and 39.7% had branch-duct IPMN. The median cyst size was 2.65 cm, invasive cancer (IC) or high-grade dysplasia (HGD) was present in 42% (n = 136); 68.9% of patients with high-risk, 40.0% of patients with worrisome, and 24.6% of patients with low risk features exhibited HGD/IC. Multivariate analysis demonstrated that only 1 of 3 high-risk features and 2 of 7 worrisome features predicted the presence of HGD/IC. Positive predictive values for HGD/ IC in patients with obstructive jaundice and lymphadenopathy were 0.83 (95% CI 0.65 to 0.94) and 0.69 (95% CI 0.39 to 0.91), respectively. In the absence of high-risk features, HGD/IC was still present in 57.4% of patients with 2 or more worrisome features. Regression analysis demonstrated that each additional worrisome factor present was additive in predicting HGD/IC in a linear fashion (odds ratio 1.39; 95% CI 1.08 to 1.80; p < 0.01).These data demonstrate that the current consensus guidelines for surgical resection of IPMN may not adequately stratify and identify patients at risk for having HGD or invasive cancer. Patients with multiple worrisome features, in the absence of high-risk factors, should be considered for resection.

webmaster@surgery.wisc.edu Copyright © 2017 The Board of Regents of the University of Wisconsin System